Product Description
Brand Boditech
Sample Type Whole Blood/ Serum
Pack Size 24T
CAT No SMFP-86
Biomarker Therapeutic Drug Monitoring
Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Infliximab can detect the presence of anti-drug antibodies against Infliximab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 12 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.
Rapid and Reliable Antibody QuantificationThe Boditech AFIAS Free Anti-Infliximab offers clinical professionals a swift solution for measuring free anti-infliximab antibodies, delivering results in about 20 minutes. Its cartridge-based system utilizes advanced fluorescence immunoassay (FIA) technology to ensure precise, reproducible measurements, all while using just 100 L of serum.
User-Friendly Touch Panel OperationThis analyzer features a modern LCD touch screen, designed for intuitive navigation and ease of use. Automated processes, auto-calibration, and multi-language support enhance workflow, making it accessible for laboratory staff and clinicians, regardless of experience level.
Portable Design for Versatile SettingsEngineered with high-impact ABS plastic, the device is lightweight and compact, allowing effortless mobility between hospital departments or clinics. Its hand-carry design ensures point-of-care flexibility without compromising on throughput or accuracy.
FAQ's of Boditech AFIAS Free Anti-Infliximab:
Q: How does the Boditech AFIAS Free Anti-Infliximab analyzer work?
A: The analyzer uses a fluorescence immunoassay (FIA) with lateral flow technology to quantitatively detect free anti-infliximab antibodies in human serum. The sample reacts with the test cartridge, and the result is interpreted through antigen-antibody fluorescence detection.
Q: What sample volume is required and what is the typical result time?
A: Only 100 L of serum is needed for each test, making it minimally invasive and efficient. The analyzer provides results in approximately 20 minutes.
Q: When should this analyzer be used in clinical practice?
A: It is ideally used when clinicians need rapid, on-site quantitation of free anti-infliximab antibodies to aid in therapeutic monitoring or managing treatment for patients utilizing infliximab.
Q: Where can the Boditech AFIAS Free Anti-Infliximab be effectively deployed?
A: Thanks to its compact, portable design, the analyzer is well-suited for various clinical settings, including hospital laboratories, specialist clinics, and point-of-care environments.
Q: What process ensures the accuracy and reliability of results?
A: The instrument features built-in auto-calibration and error alert safety functions, providing high accuracy (CV <10%) and consistent, reproducible results. It also complies with CE and IVD standards.
Q: How is data output and integration handled?
A: Results can be easily exported via USB and are compatible with Laboratory Information Systems (LIS), supporting efficient data management and clinical workflow.
Q: What are the key benefits of using this analyzer over traditional methods?
A: This device offers rapid turnaround, minimal sample volume, high accuracy, ease of use with a touch panel, and portability, enabling timely decision-making to optimize patient care.